Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is an autoimmune disease that targets hair follicles.

A woman's hair loss during treatment with specific hepatitis C drugs grew back after stopping the medication.

There is no cure for alopecia areata, and treatment success depends on the individual's situation.

Managing multiple autoimmune diseases in one patient is very challenging.

The main goal for new Alopecia Areata treatments should be significant improvement in scalp hair growth.

The man was diagnosed with lupus and improved with treatment.

New genetic discoveries in alopecia areata could lead to better treatments.

Accurate diagnosis and understanding of alopecia areata in children are crucial for proper treatment.

Different hair and nail conditions can indicate health issues and have specific treatments; accurate diagnosis is crucial before treatment.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

A woman's total hair loss was linked to a Borrelia infection and was reversed with appropriate treatment.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

Thymoma-associated multiorgan autoimmunity can cause liver damage and affects multiple organs, with limited treatment options and a generally poor prognosis.

Alopecia areata causes patchy hair loss and has no cure, but treatments like corticosteroids and minoxidil can help.

Alopecia areata causes hair loss, has no cure, and various treatments exist.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Some people with alopecia areata, a hair loss condition, get better within a year without treatment, but it can happen again.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

Recognizing the different stages of alopecia areata is crucial for accurate diagnosis and treatment.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

People with Lichen Planopilaris are more likely to have autoimmune diseases, especially Systemic Lupus Erythematosus, and less likely to have diabetes and some other common conditions.

Premature graying of hair may suggest health issues and currently lacks effective treatments.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Alopecia areata is complex, often recurring, and needs personalized treatment, especially with other health issues.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.